4D pharma plc Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price
4D pharma plc had Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price of $0.68 per share as of 2021-12-31, per its 20-F filed 2022-03-31.
Discontinued › Notes › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice · last filed 2022-03-31
- 2021-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price $0.68.
- 2020-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price $0.00.
- 2019-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price $0.00.
- 2018-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price $0.00.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price |
|---|---|
| 2021-12-31 | $0.68 20-F · filed 2022-03-31 |
| 2020-12-31 | $0.00 20-F · filed 2022-03-31 |
| 2019-12-31 | $0.00 20-F · filed 2022-03-31 |
| 2018-12-31 | $0.00 20-F/A · filed 2021-04-30 |